NCM
GMED icon

Nantahala Capital Management’s Globus Medical GMED Stock Holding History

Nantahala Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-300,000
Closed -$17.7M – 161
2025
Q2 		$17.7M Buy
+300,000
New +$19.4M 0.69% 31

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nantahala Capital Management's GMED Position: Q1 2026 in Review

Nantahala Capital Management sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 224,962 shares — an estimated $19.6M sold.

Nantahala Capital Management first reported a position in GMED in Q3 2025 and held it in 2 quarters. The position peaked at $19.6M in Q4 2025. 605 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Nantahala Capital Management reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
  • Nantahala Capital Management sold 224,962 Globus Medical shares in Q1 2026, an estimated $19.6M.
  • Nantahala Capital Management first reported a position in Globus Medical in Q3 2025 and held it in 2 quarters.
  • Nantahala Capital Management's Globus Medical position peaked at $19.6M in Q4 2025.
  • 605 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.